Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yılmaz ,Susan O’brien ,Zeev Estrov ,Farhad Ravandi ,Maria Khouri ,Elias Jabbour ,Nitin Jain ,Guillermo Garcia‐Manero ,Jorge E Cortés ,Prithviraj Bose ,Rebecca Garris ,Joseph D Khoury ,Nicholas J Short ,Tapan M Kadia ,Xuemei Wang ,Sanam Loghavi ,Srđan Verstovšek ,Jeffrey L Jorgensen ,Koichi Takahashi ,Koji Sasaki ,Sherry Pierce ,Marina Konopleva ,Hagop M Kantarjian

doi:10.1182/blood.v130.suppl_1.1434.1434

Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yılmaz , Susan O’brien + Show 21 more

https://doi.org/10.1182/blood.v130.suppl_1.1434.1434

Copy DOI

Export

Save

Cite

Journal: Blood

Publication Date: Jun 25, 2021

Affiliation: The University of Texas MD Anderson Cancer Center, University of California, Irvine Medical Center

#Research Funding #Minimal Residual Disease #Philadelphia Negative B-cell Acute Lymphoblastic Leukemia #Negative B-cell Acute Lymphoblastic Leukemia #Philadelphia Negative B-cell #Minimal Residual Disease Positive #Achieved Minimal Residual Disease Negativity #Minimal Residual Disease Negativity #Acute Lymphoblastic Leukemia #B-cell Acute Lymphoblastic Leukemia

Abstract
Full-Text
Similar Papers

Abstract

Listen

Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)